Max Robotics — Global Service Robot Directory + US Certification

About

Piergiorgio Labò is a pioneering breast surgeon whose research centers on advancing minimally invasive surgical techniques for breast cancer treatment, with a particular focus on robotic mastectomy and its comparative outcomes. His landmark 2021 study, "A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation," which has garnered over 100 citations, represents a seminal contribution to the field. This work systematically evaluated surgical, oncologic, and quality-of-life outcomes between robotic nipple-sparing mastectomy and the classical open approach, providing critical evidence that has helped shape modern surgical practice. Labò's research addresses the growing demand for less invasive options that preserve breast aesthetics without compromising oncologic safety, particularly for high-risk patients with BRCA mutations. His findings have directly influenced clinical decision-making and patient counseling, demonstrating that robotic techniques can achieve comparable outcomes while potentially reducing recovery time and improving cosmetic results. Through rigorous clinical trials and outcomes research, Labò continues to push the boundaries of breast surgery, establishing himself as a leading voice in the integration of robotic technology into oncologic breast care.